Iowa 2023-2024 Regular Session

Iowa Senate Bill SF554

Introduced
3/22/23  
Engrossed
4/24/23  
Introduced
3/22/23  
Refer
1/22/24  
Engrossed
4/24/23  

Caption

A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance, and annual reporting by pharmacy benefits managers. (Formerly SF 284.)

Impact

The enactment of SF 554 is anticipated to bring about significant changes to existing state laws relating to pharmacy benefits management. It empowers the state to procure PBM services in a competitive manner, potentially leading to savings on prescription drug costs for public sector health plans. The bill also outlines procedures for ongoing market checks and technology platform requirements, emphasizing real-time evaluation and accountability of PBM claims. This thorough approach is aimed at ensuring that state expenditures are closely monitored and optimized, potentially reducing financial burdens on taxpayers.

Summary

Senate File 554, known as The Iowa Competitive Pharmacy Benefits Managers Marketplace Act, introduces a structured approach to managing pharmacy benefits through reverse auctions. The bill mandates that the Iowa Department of Administrative Services conduct reverse auctions for pharmacy benefits managers (PBMs), allowing for competitive bidding aimed at lowering drug costs for state-funded health plans. By implementing an automated platform for these auctions, the law seeks to enhance transparency and efficiency in selecting PBM services, significantly impacting the cost structure of group insurance in Iowa.

Sentiment

The overall sentiment towards SF 554 appears to be cautiously optimistic among supporters who view it as a proactive measure to manage rising healthcare costs effectively. Proponents argue that the competitive bidding process will create better price transparency and potentially lower premiums for individuals covered under public health plans. However, there are concerns regarding the feasibility of the technology required for these auctions and the implications for smaller PBMs who may struggle to compete in such an environment, which indicates a nuanced debate surrounding the bill's efficacy.

Contention

Key points of contention include the feasibility and implementation of an automated bidding platform, as well as concerns about maintaining competitive fairness in the bidding process. Critics express worries that the reliance on technology may disadvantage smaller companies lacking in resources compared to larger PBMs. Furthermore, the bill does not apply to certain health maintenance organizations, which raises questions about equity in health insurance management across different types of health plans within the state.

Companion Bills

IA SF284

Similar To A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance for public employees.(See SF 554.)

Similar Bills

IA SSB1017

A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance for public employees.(See SF 315.)

IA SF284

A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance for public employees.(See SF 554.)

IA HF2401

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drug pricing, and providing applicability provisions. (Formerly HSB 640.)

IA SF315

A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance for public employees and including effective date provisions.(Formerly SSB 1017.)

MN SF3055

Technology platform, pharmacy benefit manager, and data protection in vendor contracts provisions modifications

MN HF2714

Pharmacy benefit manager, technology platform, and data protection provisions modified relating to vendor contracts.

LA SB180

Provides relative to state procurement of certain services by use of reverse auction technology. (8/1/21) (EN SEE FISC NOTE GF EX See Note)

LA SB65

Provides relative to state procurement of pharmacy benefit manager services by use of reverse auction technology. (8/1/23) (RE SEE FISC NOTE EX See Note)